Impact of pregabalin co-use in patients presenting with acute heroin toxicity to the European Drug Emergencies Network Plus project
Eur J Emerg Med
.
2021 Apr 1;28(2):144-146.
doi: 10.1097/MEJ.0000000000000738.
Authors
Craig Leaper
1
2
,
Alison M Dines
2
,
Paul I Dargan
2
3
,
Chris Yates
4
,
Knut Erik Hovda
5
,
Fridtjof Heyerdahl
6
7
,
Isabelle Giraudon
8
,
David M Wood
2
3
;
Euro-DEN Plus Research group
Affiliations
1
Department of Clinical Pharmacology, Chelsea and Westminster NHS Foundation Trust.
2
Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners.
3
Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
4
Emergency Department and Clinical Toxicology Unit, Hospital Universitari Son Espases, Mallorca, Spain.
5
The Norwegian CBRNe Centre of Medicine.
6
Prehospital Division, Oslo University Hospital.
7
The Norwegian Air Ambulance Foundation, Oslo, Norway.
8
Trends and Analysis Sector, Public Health Unit, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
PMID:
33674514
DOI:
10.1097/MEJ.0000000000000738
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Emergencies
Heroin* / toxicity
Humans
Illicit Drugs*
Pregabalin / adverse effects
Substances
Illicit Drugs
Pregabalin
Heroin